YOLFTbeta
30

Hebei Changshan Biochem Pharma

300255 · SHE · Healthcare / Biotechnology

18.69CNY-0.84 (-4.30%)

Price History

Full chart

Market Stats

Previous Close19.53
Open19.76
Day Range18.66 – 20.00
52-Week Range21.19 – 71.71
Volume18.95M
Market Cap21.08B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.38
Dividend Yield0.00%
Beta0.32
50-Day Avg24.70
200-Day Avg38.19

About

Hebei Changshan Biochemical Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, marketing, and sale of drugs for cardiovascular, cerebrovascular, diabetes, and cancer in China and internationally. It offers heparin sodium, calcium, and lithium, as well as heparinoid, LMW heparins, and sodium hyaluronate; dalteparin sodium, enoxaparin sodium, nadroparin calcium, and heparin sodium injections, as well as sildenafil citrate tablet; and albenatide. The company is also involved in technology development; consulting; transfer services; investment and management of medical service projects; wholesale and retail of pharmaceuticals; and diagnosis services. It exports its products to the United States, Germany, France, Italy, Spain, South Korea, Japan, Russia, India, the Philippines, and other countries. The company was founded in 1992 and is based in Shijiazhuang, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Xiaodong Gao
  • Employees1.19K
  • HeadquartersNo. 71 Menglong Street, South Zone, Shijiazhuang, China, 050800, China
  • Websitehttps://www.hbcsbio.com

Leadership

  • Mr. Xiaodong GaoChairman of the Board & GM · b. 1973
  • Ms. Xiaohua YueDeputy GM & CFO · b. 1971
  • Ms. Yunxia SunDeputy GM & Non-Independent Director · b. 1981
  • Mr. Zhenggang QieDeputy GM & Non-Independent Director · b. 1971
  • Mr. Zhongying LiuDeputy GM & Secretary · b. 1977
  • Ms. Qing ZhangDeputy General Manager · b. 1974
  • Mr. Xnjun ZhangDeputy General Manager · b. 1983
  • Mr. Zhang TaoDeputy General Manager · b. 1978
  • Ms. Guohong AnDeputy General Manager · b. 1968
  • Mr. Yanlu ChangDeputy General Manager · b. 1983

Financials

Income Statement

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue110.84M253.75M466.72M423.48M572.50M704.54M811.28M915.99M1.12B1.42B1.65B2.07B2.36B2.97B2.34B1.41B1.03B875.13M
Growth (%)-+128.94%+83.93%-9.26%+35.19%+23.06%+15.15%+12.91%+22.10%+26.98%+16.37%+25.34%+14.11%+25.56%-21.29%-39.63%-26.92%-15.10%
Cost of Revenue77.11M177.90M341.90M282.18M296.22M310.14M335.20M304.12M394.90M490.10M472.25M559.93M743.43M1.25B1.32B1.73B937.35M742.72M
Gross Profit33.73M75.85M124.82M141.30M276.28M394.40M476.08M611.87M723.51M930.07M1.18B1.51B1.62B1.72B1.02B-322.77M93.46M132.41M
Gross Margin30.43%29.89%26.74%33.37%48.26%55.98%58.68%66.80%64.69%65.49%71.42%72.97%68.55%58.01%43.71%-22.88%9.07%15.13%
Operating Expense15.46M24.61M45.24M50.41M167.22M262.14M328.60M437.60M525.46M694.51M1.01B1.25B1.31B1.46B1.00B903.55M347.50M225.21M
Operating Income18.27M51.24M79.58M90.89M109.06M132.25M147.49M174.27M198.05M235.56M172.69M262.40M309.20M262.00M20.45M-1.23B-254.04M-92.80M
Operating Margin16.48%20.19%17.05%21.46%19.05%18.77%18.18%19.03%17.71%16.59%10.45%12.67%13.08%8.83%0.88%-86.95%-24.64%-10.60%
EBITDA22.97M53.62M83.79M101.25M137.14M163.04M201.26M235.46M262.57M303.71M325.98M357.44M424.06M379.86M164.93M-1.07B-106.82M-188.91M
EBITDA Margin20.73%21.13%17.95%23.91%23.95%23.14%24.81%25.71%23.48%21.39%19.72%17.26%17.94%12.80%7.06%-75.90%-10.36%-21.59%
Net Income9.28M36.37M60.19M70.80M99.09M115.18M133.73M156.30M175.49M196.92M139.99M225.29M252.84M233.57M17.51M-1.24B-249.48M-357.90M
Net Income Margin8.38%14.33%12.90%16.72%17.31%16.35%16.48%17.06%15.69%13.87%8.47%10.88%10.70%7.87%0.75%-87.93%-24.20%-40.90%
R&D4.53M7.89M16.07M13.34M17.83M24.74M32.46M32.86M55.13M75.92M98.89M135.91M127.54M150.63M145.01M158.82M47.19M34.08M
R&D as % of Total Revenue4.09%3.11%3.44%3.15%3.11%3.51%4.00%3.59%4.93%5.35%5.98%6.56%5.40%5.07%6.21%11.26%4.58%3.89%
Interest Expense7.19M6.25M12.14M12.37M13.53M16.95M27.69M33.09M29.51M30.85M45.55M52.36M63.52M69.45M102.93M99.54M105.24M96.91M
Interest Expense % of Total Revenue6.49%2.46%2.60%2.92%2.36%2.41%3.41%3.61%2.64%2.17%2.76%2.53%2.69%2.34%4.41%7.06%10.21%11.07%

Balance Sheet

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets196.59M266.35M430.64M1.19B1.42B1.65B2.04B2.33B3.13B3.53B3.84B3.94B4.57B5.19B6.04B4.60B4.52B4.35B
Total Liabilities103.16M107.15M211.25M198.78M292.77M359.78M617.87M757.07M842.59M1.09B1.32B1.22B1.72B2.12B2.98B2.80B2.99B3.18B
Total Equity93.43M159.19M219.39M987.45M1.10B1.23B1.37B1.51B2.23B2.37B2.51B2.71B2.85B3.07B3.06B1.81B1.56B1.20B
Cash1.28M28.48M92.20M741.90M539.53M261.50M238.84M164.48M786.60M797.65M1.02B563.31M481.02M543.21M797.80M230.92M236.44M128.00M
Total Debt75.80M84.20M174.28M158.50M224.50M263.80M500.00M570.00M608.62M732.00M953.50M617.56M1.29B1.56B2.10B1.74B1.55B-
Net Debt74.52M55.72M82.08M-583.40M-315.03M2.30M261.16M405.52M-177.98M-65.65M-67.18M54.25M812.25M1.02B1.30B1.51B1.31B1.77B

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-30.83M24.21M29.25M17.04M-70.62M-15.24M-84.97M-38.14M171.96M162.28M292.81M-58.13M-183.58M2.87M3.13M33.73M56.22M55.68M
Investing Cash Flow-1.77M-23.90M-37.53M-28.93M-192.84M-267.65M-157.99M-85.64M-429.07M-246.01M-239.01M91.39M-202.85M-307.31M-431.32M-238.85M-233.76M-
Financing Cash Flow16.22M26.89M70.50M664.08M61.09M4.52M210.08M42.22M598.19M136.58M130.67M-211.30M291.67M342.96M653.44M-294.94M181.73M-
Capital Expenditure1.77M24.05M37.56M30.43M125.37M267.20M151.21M85.34M96.52M158.30M234.85M163.40M199.78M308.08M431.22M239.32M239.59M123.36M
Free Cash Flow-32.60M159.12K-8.31M-13.38M-195.99M-282.45M-236.17M-123.48M75.44M3.98M57.96M-221.53M-383.36M-305.21M-428.10M-205.60M-183.37M-67.68M
Dividends Paid6.88M6.05M8.75M14.45M35.10M34.78M26.12M47.94M51.47M47.72M61.44M26.18M12.15M61.89M124.00M107.73M119.93M118.69M
FCF to OCF105.76%0.66%-28.42%-78.54%277.52%1852.80%277.96%323.77%43.87%2.45%19.80%381.11%208.82%-10628.97%-13696.86%-609.61%-326.18%-121.54%
Dividend Paid to FCF-21.09%3799.42%-105.27%-107.94%-17.91%-12.31%-11.06%-38.83%68.23%1200.11%106.01%-11.82%-3.17%-20.28%-28.97%-52.40%-65.40%-175.38%

Earnings

Report DateSep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 21, 2014Oct 22, 2014Feb 23, 2015Apr 25, 2015Aug 21, 2015Oct 22, 2015Feb 26, 2016Apr 22, 2016Aug 20, 2016Oct 14, 2016Feb 24, 2017Apr 25, 2017Aug 25, 2017Oct 27, 2017Apr 26, 2018Aug 20, 2018Oct 28, 2018Apr 22, 2019Aug 15, 2019Oct 30, 2019Apr 29, 2020Aug 26, 2020Oct 30, 2020Apr 29, 2021Aug 27, 2021Oct 29, 2021Apr 29, 2022Aug 26, 2022Oct 28, 2022Apr 27, 2023Aug 31, 2023Oct 25, 2023May 20, 2024Aug 29, 2024Oct 30, 2024Apr 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------0.06-0.080.040.08----------------------------------
EPS Actual0.010.030.020.030.010.050.030.040.020.050.030.040.020.070.030.040.030.080.030.050.030.080.050.040.050.050.060.060.060.070.080.030.090.080.070.100.050.030.040.000.00-0.17-0.25-0.070.020.06-0.28-0.04-0.02-0.340.01-0.02
Surprise-------------16.67%--50.00%-25.00%0.00%----------------------------------
Timing-----------After-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours--------Pre-market-----After-hours--------

Key Statistics & Ratios

Market Cap21.08B
Enterprise Value24.32B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales24.53
Price / Book18.29
EPS-0.38
Book Value1.29
Revenue (TTM)859.35M
Gross Profit (TTM)40.41M
EBITDA-151.31M
Profit Margin-40.21%
Operating Margin-1.16%
Return on Equity-26.68%
Return on Assets-3.02%
Shares Outstanding919.06M
Shares Float593.76M
Beta0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.01Jun 27, 2023
20221×
0.03Jun 2, 2022
20201×
0.01Jul 9, 2020
20191×
0.03Jul 11, 2019
20181×
0.02Jun 22, 2018
20171×
0.01Jun 29, 2017
20161×
0.03Apr 20, 2016
20151×
0.02Apr 30, 2015
20131×
0.02Jun 6, 2013
20121×
0.03Jul 10, 2012

Stock Splits

  • Apr 20, 201618:10
  • Apr 30, 201525:10
  • Jul 10, 201217:10